Cardinal Health, Inc. $CAH Shares Bought by Corient Private Wealth LLC

Corient Private Wealth LLC boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 86,229 shares of the company’s stock after purchasing an additional 4,636 shares during the period. Corient Private Wealth LLC’s holdings in Cardinal Health were worth $17,722,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CAH. Norges Bank purchased a new position in shares of Cardinal Health during the 4th quarter valued at approximately $790,344,000. Wellington Management Group LLP increased its holdings in Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after acquiring an additional 3,511,579 shares in the last quarter. Holocene Advisors LP raised its position in Cardinal Health by 141.4% during the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after acquiring an additional 1,128,358 shares during the period. Marshall Wace LLP raised its position in Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after acquiring an additional 884,648 shares during the period. Finally, Barclays PLC lifted its holdings in Cardinal Health by 109.3% during the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after purchasing an additional 827,446 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Up 2.8%

Cardinal Health stock opened at $229.06 on Wednesday. The company has a fifty day simple moving average of $204.76 and a 200-day simple moving average of $209.61. The firm has a market capitalization of $53.65 billion, a price-to-earnings ratio of 35.02, a PEG ratio of 1.22 and a beta of 0.52. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period last year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio is 31.19%.

Analyst Upgrades and Downgrades

CAH has been the topic of several research analyst reports. Wells Fargo & Company dropped their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. William Blair initiated coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Morgan Stanley lifted their price objective on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. Barclays boosted their price objective on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 24th. Finally, Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday, June 15th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.